副鼻腔炎治療の世界市場レポート 2025年

副鼻腔炎治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.1％で39億9,000万米ドルに成長します。予測期間の成長は、副鼻腔炎の有病率の上昇、高齢者人口の増加、ヘルスケア支出の増加、アレルギーの有病率の上昇、効率的な治療ソリューションへのニーズの高まりに起因しています。予測期間における主な動向としては、副鼻腔炎手術の技術的進歩、点鼻薬の需要、新しいドラッグデリバリー技術の開発、治療オプションの利用可能性、技術の進歩などが挙げられます。

喘息のような呼吸器疾患の有病率の上昇は、今後数年間の副鼻腔炎治療市場の成長を促進すると予測されます。喘息は気道の炎症と狭窄を特徴とする慢性疾患で、喘鳴、息切れ、胸部圧迫感、咳などの症状を繰り返し引き起こします。喘息の罹患率の増加は、環境汚染、アレルゲンへの暴露、遺伝的要因、都市化、ライフスタイルの変化、呼吸器感染症などの要因に起因しています。副鼻腔炎治療は、鼻の詰まりを取り除き、排水を改善することで点鼻薬を減らし、呼吸器系に影響を与える二次感染のリスクを最小限に抑えるという重要な役割を担っています。例えば、2023年11月、オーストラリアの非営利団体であるNational Asthma Councilは、2022年の喘息関連死亡者数を467人（うち女性299人、男性168人）と報告し、2021年の死亡者数355人からの増加を反映しました。このように、喘息の有病率の増加が副鼻腔炎治療市場の拡大に寄与しています。

副鼻腔炎治療市場の主なプレーヤーは、効果を高め、副作用を最小限に抑え、より便利な投与オプションを提供するために、ステロイド点鼻スプレーなどの新薬を開発することで革新を進めています。ステロイド点鼻薬は抗炎症作用で知られ、様々な鼻の症状に対応するために投与されます。例えば、Optinose Inc.は2024年3月にXHANCEを発表しました。これは、18歳以上の成人において、鼻ポリープの有無にかかわらず、慢性鼻副鼻腔炎の効果的な治療のために、局所ステロイドを鼻腔の奥深くまで投与するExhalation Delivery System（EDS）を利用したFDA認可の点鼻薬です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界副鼻腔炎治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の副鼻腔炎治療市場：成長率分析
• 世界の副鼻腔炎治療市場の実績：規模と成長, 2019-2024
• 世界の副鼻腔炎治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界副鼻腔炎治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の副鼻腔炎治療市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鎮痛剤
• 抗生物質
• 抗ヒスタミン薬
• 手術
• コルチコステロイド
• スルホンアミド
• キノロン
• 世界の副鼻腔炎治療市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 急性副鼻腔炎
• 亜急性副鼻腔炎
• 慢性副鼻腔炎
• 世界の副鼻腔炎治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• トピック
• 鼻腔
• オーラル
• 注射剤
• 世界の副鼻腔炎治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オンライン薬局
• 小売薬局
• 病院薬局
• 世界の副鼻腔炎治療市場鎮痛剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 市販の鎮痛剤（アセトアミノフェン、イブプロフェン）
• 処方鎮痛薬
• 鎮痛剤（鼻づまり解消薬配合）
• 世界の副鼻腔炎治療市場抗生物質の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ペニシリン系抗生物質
• セファロスポリン
• マクロライド（アジスロマイシン）
• フルオロキノロン（レボフロキサシン）
• アミノグリコシド
• 広域スペクトル抗生物質
• 世界の副鼻腔炎治療市場抗ヒスタミン薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 第一世代抗ヒスタミン薬（ジフェンヒドラミン）
• 第二世代抗ヒスタミン薬（ロラタジン、セチリジン）
• 鼻腔用抗ヒスタミン薬（アゼラスチン）
• 世界の副鼻腔炎治療市場、手術の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機能的内視鏡下副鼻腔手術（フェス）
• バルーンサイナプラシー
• 副鼻腔ドレナージと除去
• 鼻中隔形成術（構造上の問題）
• 慢性副鼻腔炎に対するその他の外科的介入
• 世界の副鼻腔炎治療市場コルチコステロイドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口コルチコステロイド（プレドニゾン）
• 鼻腔ステロイドスプレー（フルチカゾン、ブデソニド）
• 副鼻腔炎に対する局所コルチコステロイド
• 世界の副鼻腔炎治療市場、スルホンアミドのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• スルファメトキサゾールまたはトリメトプリム（バクトリム）
• 副鼻腔感染症に対するその他のスルホンアミド系抗生物質
• 世界の副鼻腔炎治療市場キノロン類のサブセグメンテーション（種類別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• シプロフロキサシン
• レボフロキサシン
• モキシフロキサシン
• 副鼻腔炎に対するその他のフルオロキノロン

第7章 地域別・国別分析

• 世界の副鼻腔炎治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の副鼻腔炎治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 副鼻腔炎治療市場：競合情勢
• 副鼻腔炎治療市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Co. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Medtronic Plc
• GlaxoSmithKline Plc
• Gilead Sciences Inc.
• Stryker Corp.
• Teva Pharmaceutical Industries Ltd.
• Baxter International Inc.
• Fresenius Kabi AG
• Olympus Corporation
• Boehringer Ingelheim GmbH
• Smith And Nephew Plc
• Perrigo Company plc
• Dr. Reddy's Laboratories Ltd.
• Aurobindo Pharma
• Cipla Ltd.
• Hikma Pharmaceuticals Plc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 副鼻腔炎治療市場2029：新たな機会を提供する国
• 副鼻腔炎治療市場2029：新たな機会を提供するセグメント
• 副鼻腔炎治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Sinusitis treatment encompasses a spectrum of techniques and therapies aimed at mitigating its symptoms. As an inflammation or infection of the sinuses, sinusitis prompts the utilization of diverse treatment approaches, tailored to the severity and underlying cause of the condition, while also considering the individual's health status and medical history.

The primary treatment modalities for sinusitis include analgesics, antibiotics, antihistamines, surgery, corticosteroids, sulfonamides, and quinolones. Analgesics are medications formulated to alleviate pain without inducing unconsciousness. The various types of sinusitis include acute sinusitis, sub-acute sinusitis, and chronic sinusitis. These treatments are administered through various routes, including topical, nasal, oral, and injectable, and are typically available through online pharmacies, retail pharmacies, and hospital pharmacies.

The sinusitis treatment market research report is one of a series of new reports from The Business Research Company that provides sinusitis treatment market statistics, including sinusitis treatment industry global market size, regional shares, competitors with a sinusitis treatment market share, detailed sinusitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the sinusitis treatment industry. This sinusitis treatment research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sinusitis treatment market size has grown strongly in recent years. It will grow from $2.95 billion in 2024 to $3.14 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increased demand for diagnostic tests and antibiotics, increased use of generic drugs, health awareness, improved intra-nasal drug delivery, government support for healthcare programs and research.

The sinusitis treatment market size is expected to see strong growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to rising prevalence rate of sinusitis, growing geriatric population, increasing healthcare expenditure, rising prevalence of allergies, growing need for efficient treatment solutions. Major trends in the forecast period include technological advancements in sinusitis surgery, demand for nasal sprays, development of new drug delivery technologies, availability of treatment options, advancements in technology.

The rising prevalence of respiratory conditions like asthma is anticipated to drive the growth of the sinusitis treatment market in the coming years. Asthma is a chronic condition marked by inflammation and narrowing of the airways, causing recurrent symptoms such as wheezing, shortness of breath, chest tightness, and coughing. The increasing incidence of asthma is attributed to factors such as environmental pollution, allergen exposure, genetic factors, urbanization, lifestyle changes, and respiratory infections. Sinusitis treatments play a crucial role in clearing nasal blockages and improving drainage, thereby reducing postnasal drip and minimizing the risk of secondary infections that can impact the respiratory system. For example, in November 2023, the National Asthma Council, an Australian non-profit organization, reported 467 asthma-related deaths in 2022, including 299 females and 168 males, reflecting an increase from 355 deaths in 2021. Thus, the growing prevalence of asthma is contributing to the expansion of the sinusitis treatment market.

Key players in the sinusitis treatment market are innovating by developing new drugs such as steroid nasal sprays to enhance efficacy, minimize side effects, and provide more convenient dosing options. Steroid nasal sprays, known for their anti-inflammatory properties, are administered to address various nasal conditions. For example, Optinose Inc. introduced XHANCE in March 2024, an FDA-approved nasal spray utilizing the Exhalation Delivery System (EDS) to deliver topical steroids deep into the nasal cavity for effective treatment of chronic rhinosinusitis, with or without nasal polyps, in adults aged 18 and above.

In May 2022, Medtronic Plc acquired Intersect ENT for $1.1 billion, expanding its portfolio in sinusitis treatment. This acquisition enables Medtronic to leverage Intersect ENT's expertise in developing innovative products for sinus procedures, aimed at improving post-operative outcomes and treating nasal polyps. Intersect ENT's drug-delivery devices for ENT clinicians complement Medtronic's offerings, reinforcing its position in the sinusitis treatment market.

Major companies operating in the sinusitis treatment market are Johnson & Johnson, Pfizer Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Co., Medtronic Plc, GlaxoSmithKline Plc, Gilead Sciences Inc., Stryker Corp., Teva Pharmaceutical Industries Ltd., Baxter International Inc., Fresenius Kabi AG, Olympus Corporation, Boehringer Ingelheim GmbH, Smith And Nephew Plc, Perrigo Company plc, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma, Cipla Ltd., Hikma Pharmaceuticals Plc, Apotex Inc., Lupin Pharmaceuticals Inc., Bionorica SE, Wockhardt Ltd., Zydus Cadila Ltd., Intersect ENT Inc.

North America was the largest region in the sinusitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sinusitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sinusitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sinusitis treatment market includes revenues earned by entities by diagnostic tests, medications, nasal irrigation and saline rinses, surgical treatments and related nasal drug delivery devices, acupressure, acupuncture, and facial massage. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sinusitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sinusitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sinusitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sinusitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Analgesics; Antibiotics; Antihistamines; Surgery; Corticosteroids; Sulfonamides; Quinolones
• 2) By Disease Type: Acute Sinusitis; Sub-Acute Sinusitis; Chronic Sinusitis
• 3) By Route Of Administration: Topical; Nasal; Oral; Injectable
• 4) By Distribution Channel: Online Pharmacies; Retail Pharmacies; Hospital Pharmacies
• Subsegments:
• 1) By Analgesics: Over-The-Counter Pain Relievers (Acetaminophen, Ibuprofen); Prescription Pain Medications; Combination Pain Relief Medications (With Decongestants)
• 2) By Antibiotics: Penicillin-Based Antibiotics; Cephalosporins; Macrolides (Azithromycin); Fluoroquinolones (Levofloxacin); Aminoglycosides; Broad-Spectrum Antibiotics
• 3) By Antihistamines: First-Generation Antihistamines (Diphenhydramine); Second-Generation Antihistamine (Loratadine, Cetirizine); Nasal Antihistamines (Azelastine)
• 4) By Surgery: Functional Endoscopic Sinus Surgery (Fess); Balloon Sinuplasty; Sinus Drainage And Removal; Septoplasty (For Structural Issues); Other Surgical Interventions For Chronic Sinusitis
• 5) By Corticosteroids: Oral Corticosteroids (Prednisone); Nasal Steroid Sprays (Fluticasone, Budesonide); Topical Corticosteroids For Sinus Inflammation
• 6) By Sulfonamides: Sulfamethoxazole Or Trimethoprim (Bactrim); Other Sulfonamide-Based Antibiotics For Sinus Infections
• 7) By Quinolones: Ciprofloxacin; Levofloxacin; Moxifloxacin; Other Fluoroquinolones For Sinusitis
• Companies Mentioned: Johnson & Johnson; Pfizer Inc.; AbbVie Inc.; Bayer AG; Bristol-Myers Squibb Co.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sinusitis Treatment Market Characteristics

3. Sinusitis Treatment Market Trends And Strategies

4. Sinusitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Sinusitis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Sinusitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Sinusitis Treatment Market Growth Rate Analysis
• 5.4. Global Sinusitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Sinusitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Sinusitis Treatment Total Addressable Market (TAM)

6. Sinusitis Treatment Market Segmentation

• 6.1. Global Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Analgesics
• Antibiotics
• Antihistamines
• Surgery
• Corticosteroids
• Sulfonamides
• Quinolones
• 6.2. Global Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Sinusitis
• Sub-Acute Sinusitis
• Chronic Sinusitis
• 6.3. Global Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical
• Nasal
• Oral
• Injectable
• 6.4. Global Sinusitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online Pharmacies
• Retail Pharmacies
• Hospital Pharmacies
• 6.5. Global Sinusitis Treatment Market, Sub-Segmentation Of Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Over-The-Counter Pain Relievers (Acetaminophen, Ibuprofen)
• Prescription Pain Medications
• Combination Pain Relief Medications (With Decongestants)
• 6.6. Global Sinusitis Treatment Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Penicillin-Based Antibiotics
• Cephalosporins
• Macrolides (Azithromycin)
• Fluoroquinolones (Levofloxacin)
• Aminoglycosides
• Broad-Spectrum Antibiotics
• 6.7. Global Sinusitis Treatment Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• First-Generation Antihistamines (Diphenhydramine)
• Second-Generation Antihistamine (Loratadine, Cetirizine)
• Nasal Antihistamines (Azelastine)
• 6.8. Global Sinusitis Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Functional Endoscopic Sinus Surgery (Fess)
• Balloon Sinuplasty
• Sinus Drainage And Removal
• Septoplasty (For Structural Issues)
• Other Surgical Interventions For Chronic Sinusitis
• 6.9. Global Sinusitis Treatment Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Corticosteroids (Prednisone)
• Nasal Steroid Sprays (Fluticasone, Budesonide)
• Topical Corticosteroids For Sinus Inflammation
• 6.10. Global Sinusitis Treatment Market, Sub-Segmentation Of Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sulfamethoxazole Or Trimethoprim (Bactrim)
• Other Sulfonamide-Based Antibiotics For Sinus Infections
• 6.11. Global Sinusitis Treatment Market, Sub-Segmentation Of Quinolones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ciprofloxacin
• Levofloxacin
• Moxifloxacin
• Other Fluoroquinolones For Sinusitis

7. Sinusitis Treatment Market Regional And Country Analysis

• 7.1. Global Sinusitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Sinusitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sinusitis Treatment Market

• 8.1. Asia-Pacific Sinusitis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sinusitis Treatment Market

• 9.1. China Sinusitis Treatment Market Overview
• 9.2. China Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sinusitis Treatment Market

• 10.1. India Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sinusitis Treatment Market

• 11.1. Japan Sinusitis Treatment Market Overview
• 11.2. Japan Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sinusitis Treatment Market

• 12.1. Australia Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sinusitis Treatment Market

• 13.1. Indonesia Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sinusitis Treatment Market

• 14.1. South Korea Sinusitis Treatment Market Overview
• 14.2. South Korea Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sinusitis Treatment Market

• 15.1. Western Europe Sinusitis Treatment Market Overview
• 15.2. Western Europe Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sinusitis Treatment Market

• 16.1. UK Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sinusitis Treatment Market

• 17.1. Germany Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sinusitis Treatment Market

• 18.1. France Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sinusitis Treatment Market

• 19.1. Italy Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sinusitis Treatment Market

• 20.1. Spain Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sinusitis Treatment Market

• 21.1. Eastern Europe Sinusitis Treatment Market Overview
• 21.2. Eastern Europe Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sinusitis Treatment Market

• 22.1. Russia Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sinusitis Treatment Market

• 23.1. North America Sinusitis Treatment Market Overview
• 23.2. North America Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sinusitis Treatment Market

• 24.1. USA Sinusitis Treatment Market Overview
• 24.2. USA Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sinusitis Treatment Market

• 25.1. Canada Sinusitis Treatment Market Overview
• 25.2. Canada Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sinusitis Treatment Market

• 26.1. South America Sinusitis Treatment Market Overview
• 26.2. South America Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sinusitis Treatment Market

• 27.1. Brazil Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sinusitis Treatment Market

• 28.1. Middle East Sinusitis Treatment Market Overview
• 28.2. Middle East Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sinusitis Treatment Market

• 29.1. Africa Sinusitis Treatment Market Overview
• 29.2. Africa Sinusitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Sinusitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Sinusitis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sinusitis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Sinusitis Treatment Market Competitive Landscape
• 30.2. Sinusitis Treatment Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Co. Overview, Products and Services, Strategy and Financial Analysis

31. Sinusitis Treatment Market Other Major And Innovative Companies

• 31.1. Medtronic Plc
• 31.2. GlaxoSmithKline Plc
• 31.3. Gilead Sciences Inc.
• 31.4. Stryker Corp.
• 31.5. Teva Pharmaceutical Industries Ltd.
• 31.6. Baxter International Inc.
• 31.7. Fresenius Kabi AG
• 31.8. Olympus Corporation
• 31.9. Boehringer Ingelheim GmbH
• 31.10. Smith And Nephew Plc
• 31.11. Perrigo Company plc
• 31.12. Dr. Reddy's Laboratories Ltd.
• 31.13. Aurobindo Pharma
• 31.14. Cipla Ltd.
• 31.15. Hikma Pharmaceuticals Plc

32. Global Sinusitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sinusitis Treatment Market

34. Recent Developments In The Sinusitis Treatment Market

35. Sinusitis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Sinusitis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Sinusitis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Sinusitis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer